EE200300339A - Helicobacter pylory uudsed retseptorid ja nende kasutamine - Google Patents

Helicobacter pylory uudsed retseptorid ja nende kasutamine

Info

Publication number
EE200300339A
EE200300339A EEP200300339A EEP200300339A EE200300339A EE 200300339 A EE200300339 A EE 200300339A EE P200300339 A EEP200300339 A EE P200300339A EE P200300339 A EEP200300339 A EE P200300339A EE 200300339 A EE200300339 A EE 200300339A
Authority
EE
Estonia
Prior art keywords
receptors
novel helicobacter
helicobacter pylory
pylory
novel
Prior art date
Application number
EEP200300339A
Other languages
English (en)
Estonian (et)
Inventor
Miller-Podraza Halina
Teneberg Susann
�ngstr�m Jonas
Karlsson Karl-Anders
Natunen Jari
Original Assignee
Biotie Therapies Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Corp. filed Critical Biotie Therapies Corp.
Publication of EE200300339A publication Critical patent/EE200300339A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EEP200300339A 2001-01-19 2002-01-18 Helicobacter pylory uudsed retseptorid ja nende kasutamine EE200300339A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010118A FI20010118A (fi) 2001-01-19 2001-01-19 Uudet helicobacter pylori reseptorit ja niiden käyttö
PCT/FI2002/000043 WO2002056893A1 (en) 2001-01-19 2002-01-18 Novel receptors for $i(helicobacter pylori) and use thereof

Publications (1)

Publication Number Publication Date
EE200300339A true EE200300339A (et) 2003-10-15

Family

ID=8560066

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300339A EE200300339A (et) 2001-01-19 2002-01-18 Helicobacter pylory uudsed retseptorid ja nende kasutamine

Country Status (19)

Country Link
US (1) US20040096465A1 (xx)
EP (1) EP1359922A1 (xx)
JP (1) JP2004519459A (xx)
KR (1) KR100886777B1 (xx)
CN (1) CN100455290C (xx)
AU (1) AU2002229792B2 (xx)
CA (1) CA2434350A1 (xx)
CZ (1) CZ20031914A3 (xx)
EE (1) EE200300339A (xx)
FI (1) FI20010118A (xx)
HU (1) HUP0302790A3 (xx)
IL (1) IL156992A0 (xx)
NO (1) NO20033270L (xx)
NZ (1) NZ526906A (xx)
PL (1) PL363617A1 (xx)
RU (1) RU2306140C2 (xx)
SK (1) SK10042003A3 (xx)
WO (1) WO2002056893A1 (xx)
ZA (1) ZA200305155B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20011671A (fi) * 2001-08-20 2003-02-21 Carbion Oy Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
JP2005526711A (ja) * 2002-01-18 2005-09-08 バイオティ セラピィーズ コープ ヘリコバクターピロリに対する新規結合エピトープおよびその用途
JP5219329B2 (ja) * 2002-06-28 2013-06-26 ネステク、リミテッド 下痢の予防又は治療用の医薬組成物
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
WO2004065400A1 (en) * 2003-01-20 2004-08-05 Glykos Finland Oy Novel binding epitopes for helicobacter pylori and use thereof
JP5035787B2 (ja) * 2005-10-04 2012-09-26 焼津水産化学工業株式会社 α−１、４結合型Ｎ−アセチルグルコサミン含有Ｏ−グリカン型糖鎖の分泌促進剤並びにこれを含有するヘリコバクターピロリ菌を原因とする病態の治療予防剤
JP5140246B2 (ja) * 2006-03-15 2013-02-06 公益財団法人野口研究所 Ｎ−アセチルグルコサミンの誘導体を含有するピロリ菌増殖抑制剤
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
US8075674B2 (en) 2006-11-30 2011-12-13 Donaldson Company, Inc. Filter apparatus with pulse cleaning and methods for pulse cleaning filters
MY159076A (en) * 2007-11-08 2016-12-15 Nestec Sa Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
ES2551599T3 (es) * 2012-03-19 2015-11-20 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vacunas de polisacárido antígeno-glicolípido conjugado
EP2911676B1 (en) * 2012-10-29 2020-05-20 The Board of Trustees of the University of Arkansas Novel mucosal adjuvants and delivery systems
CN112023037A (zh) * 2020-09-09 2020-12-04 四川大学 一种聚糖在制备对Hp感染的预防和治疗产品中的应用、产品及制备方法
CN112285338B (zh) * 2020-10-20 2023-04-28 四川大学华西医院 一种copd诊断试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8203925D0 (sv) * 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
JPH1045602A (ja) * 1996-07-31 1998-02-17 Motoyasu Murakami ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof

Also Published As

Publication number Publication date
WO2002056893A8 (en) 2003-11-13
PL363617A1 (en) 2004-11-29
KR20040018329A (ko) 2004-03-03
ZA200305155B (en) 2004-07-19
AU2002229792B2 (en) 2007-08-16
CA2434350A1 (en) 2002-07-25
RU2003125370A (ru) 2005-02-10
WO2002056893A1 (en) 2002-07-25
HUP0302790A3 (en) 2010-01-28
NO20033270L (no) 2003-09-19
HUP0302790A2 (hu) 2003-11-28
CN100455290C (zh) 2009-01-28
FI20010118A (fi) 2002-07-20
EP1359922A1 (en) 2003-11-12
SK10042003A3 (sk) 2003-11-04
IL156992A0 (en) 2004-02-08
JP2004519459A (ja) 2004-07-02
NZ526906A (en) 2005-03-24
KR100886777B1 (ko) 2009-03-04
CN1525862A (zh) 2004-09-01
NO20033270D0 (no) 2003-07-18
RU2306140C2 (ru) 2007-09-20
US20040096465A1 (en) 2004-05-20
FI20010118A0 (fi) 2001-01-19
CZ20031914A3 (cs) 2004-04-14

Similar Documents

Publication Publication Date Title
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DK1671949T3 (da) Substituerede pyridinylaminer
IS7291A (is) Merkt kirni
DE60200262D1 (de) Flachkabel
IS6915A (is) Lyfjablanda
BR0210619A (pt) composição
DE50206892D1 (de) Substituierte imidazotriazinone
DE60218081D1 (de) Markierungsteilchen
NO20035121D0 (no) Ny anvendelse
IS7081A (is) Lyfjablanda
EE200300339A (et) Helicobacter pylory uudsed retseptorid ja nende kasutamine
FR2830063B1 (fr) Joint homocinetique
DK1373228T3 (da) Substituerede fluoralkoxyphenylsulfonylurinstoffer
EE200400080A (et) Stendid
DK1406858T3 (da) Substituerede 4-aminocyklohexanoler
DE50202942D1 (de) Basenhältige mikronährstoffmischung
DE50213801D1 (de) Gelenk
DK1392670T3 (da) Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater
NO20011568L (no) Spredemikset komposittfiber
ITTO20020747A0 (it) Composizione
NO20033919D0 (no) Ny anvendelse
DE50209548D1 (de) Substituierte 1-aryl-but-3-enylamin- und 1-aryl-but-2-enylaminverbindungen
DE60219418T8 (de) Silanylphenole und -naphthole
ITTO20020745A0 (it) Composizione